Hensoldt Trades at a Crossroads: Fresh Sales Leadership, Trimmed Targets and a €10 Billion Long Game
Published on 11/14/2026 at 19:11 | Editorial boerse-global.de
Morgan Stanley trimmed its price target on Hensoldt from €82 to €81 on Tuesday while keeping its "Equal Weight" rating intact — the second such adjustment in less than a week, following Cantor Fitzgerald's move on Thursday. Neither downgrade came with a change in conviction: Cantor Fitzgerald cut its target from €105 to €93 but stuck with "Overweight." The shares, for their part, added 1.1% on the day of the Morgan Stanley revision.
The two revisions bookend a busy stretch of broker activity. On Wednesday, three more research houses raised their targets while holding their ratings steady, and a fourth lowered its mark. Their new objectives span a range of €87 to €105, with recommendations running from "Neutral" to "Buy." JPMorgan, according to media reports, upgraded the stock from "Neutral" to "Overweight" and lifted its target from €100 to €105. Deutsche Bank Research moved the other way on the same day, cutting its target to €100 while leaving its "Buy" recommendation in place — a combination that points to a broadly positive view with differing expectations for how much valuation headroom remains.
A New Face for the Growth Push
Hensoldt announced Tuesday that Viktoria Stürmer-Kuchelmeister will take charge of Global Sales, Business Development & Strategy on 1 January 2027, joining the Executive Committee. Russell Gould leaves the company on 31 December 2026. The handover lands precisely at the start of the phase on which much of the company's longer-range planning rests — from 2027, Hensoldt expects annual revenue growth of 15% to 20%.
For investors, the appointment sets a concrete date ahead of the long-term growth ambitions. The question that matters is whether Hensoldt can pair expansion with higher profitability, and the leadership change is an organisational step toward that end; its economic significance will be measured in the business performance that follows.
Should investors sell immediately? Or is it worth buying Hensoldt?
The Margin Is the Real Test
At its capital markets day on Tuesday, Hensoldt confirmed its revenue ambition of €6 billion for 2030, alongside a targeted adjusted EBITDA margin of around 21% for that period. It also set out, for the first time, a revenue ambition of €10 billion for 2035. The two figures belong together in any assessment: revenue describes the intended scale of the business, the margin its operating earning power on an adjusted basis. A successful execution would have to deliver on both fronts.
There are operational footholds for the optimistic case. In the first nine months of 2026, revenue rose 21.3% while adjusted EBITDA climbed 33.0% — meaning adjusted operating profit outpaced sales. Should that pattern persist as revenue continues to rise, it would support the intended combination of expansion and improved profitability, and give the incoming sales and strategy leadership a favourable starting position.
Near-Term Guidance Offers a Firmer Yardstick
For the full year 2026, Hensoldt has sharpened its forecast to around €2.8 billion in revenue and an adjusted EBITDA margin of roughly 19.0%. That gives investors a nearer-term benchmark than the long-range ambitions. In the positive scenario, the company first meets these targets and then develops the business along the announced growth path — at which point the new leadership lineup could be read as support for a trajectory already grounded in operations. Measurable results across several reporting periods would be the deciding factor.
Hensoldt at a turning point? This analysis reveals what investors need to know now.
The risk sits in satisfying several demanding goals at once. Hensoldt would need to hit its expected growth while simultaneously lifting adjusted profitability. Slower expansion or lagging margin development would weaken the persuasive force of the long-term plan. The distant horizon adds a further complication: the €10 billion revenue goal for 2035 broadens the perspective but ties the investment case more heavily to whether the company reaches its nearer objectives first.
The Calendar Sets the Next Milestone
As long as Hensoldt advances growth and margin improvement in tandem, the positive case remains operationally defensible. Should either lose momentum, the long-term revenue outlook would have to be weighted more cautiously. The next concrete date on the personnel calendar is Stürmer-Kuchelmeister's start on 1 January 2027, when the announced change in sales and strategy takes effect. What counts thereafter is how that setup proves itself in the business development — credible progress would mean revenue growth and adjusted earning power moving together toward the confirmed targets. Investors are effectively choosing between faith in that execution path and a demand for the next operational proof.
Ad
Hensoldt Stock: New Analysis - 14 November
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
